| Prevention of HIV-1 infection with early antiretroviral therapy MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England journal of medicine 365 (6), 493-505, 2011 | 8734 | 2011 |
| Antiretroviral therapy for the prevention of HIV-1 transmission MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England Journal of Medicine 375 (9), 830-839, 2016 | 1815 | 2016 |
| Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ... The Lancet infectious diseases 14 (4), 281-290, 2014 | 631 | 2014 |
| Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) SH Eshleman, M Mracna, LA Guay, M Deseyve, S Cunningham, ... Aids 15 (15), 1951-1957, 2001 | 551 | 2001 |
| Cabotegravir for HIV prevention in cisgender men and transgender women RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ... New England Journal of Medicine 385 (7), 595-608, 2021 | 465 | 2021 |
| The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency SH Shakin-Eshleman, SL Spitalnik, L Kasturi Journal of Biological Chemistry 271 (11), 6363-6366, 1996 | 393 | 1996 |
| The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency JL Mellquist, L Kasturi, SL Spitalnik, SH Shakin-Eshleman Biochemistry 37 (19), 6833-6837, 1998 | 352 | 1998 |
| Effect of universal testing and treatment on HIV incidence—HPTN 071 (PopART) RJ Hayes, D Donnell, S Floyd, N Mandla, J Bwalya, K Sabapathy, B Yang, ... New England Journal of Medicine 381 (3), 207-218, 2019 | 297 | 2019 |
| Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission JB Jackson, G Becker-Pergola, LA Guay, P Musoke, M Mracna, ... Aids 14 (11), F111-F115, 2000 | 287 | 2000 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 282 | 2015 |
| Antiretroviral treatment for children with peripartum nevirapine exposure P Palumbo, JC Lindsey, MD Hughes, MF Cotton, R Bobat, T Meyers, ... New England Journal of Medicine 363 (16), 1510-1520, 2010 | 271 | 2010 |
| The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial A Pettifor, C MacPhail, JP Hughes, A Selin, J Wang, FX Gómez-Olivé, ... The Lancet Global Health 4 (12), e978-e988, 2016 | 252 | 2016 |
| Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial S Delany-Moretlwe, JP Hughes, P Bock, SG Ouma, P Hunidzarira, ... The Lancet, 2022 | 240 | 2022 |
| Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children A Violari, JC Lindsey, MD Hughes, HA Mujuru, L Barlow-Mosha, ... New England Journal of Medicine 366 (25), 2380-2389, 2012 | 233 | 2012 |
| Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the … T Flys, DV Nissley, CW Claasen, D Jones, C Shi, LA Guay, P Musoke, ... The Journal of infectious diseases 192 (1), 24-29, 2005 | 232 | 2005 |
| Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP SH Eshleman, DR Hoover, S Chen, SE Hudelson, LA Guay, A Mwatha, ... The Journal of infectious diseases 192 (1), 30-36, 2005 | 229 | 2005 |
| Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women KH Mayer, LA Maslankowski, F Gai, WM El-Sadr, J Justman, A Kwiecien, ... Aids 20 (4), 543-551, 2006 | 224 | 2006 |
| Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061 BA Koblin, KH Mayer, SH Eshleman, L Wang, S Mannheimer, C Rio, ... PloS one 8 (7), e70413, 2013 | 216 | 2013 |
| Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations W Huang, SH Eshleman, J Toma, S Fransen, E Stawiski, EE Paxinos, ... Journal of virology 81 (15), 7885-7893, 2007 | 207 | 2007 |
| The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein L Kasturi, JR Eshleman, WH Wunner, SH Shakin-Eshleman Journal of Biological Chemistry 270 (24), 14756-14761, 1995 | 206 | 1995 |
